| | Subset of SSc | Acrosclerosis ( = 29) | Diffuse ( = 56) | (acro. versus diffuse) |
| | Females, (%) | 25 (86,2) | 49 (87,5) | 1 | | Age at diagnosis, years, mean (SD) | 54,9 (16,2) | 53 (18,3) | 0,7 | | Duration of Raynaud’s prior to diagnosis, years, mean (SD) | 5,5 (1) | 1,9 (0,8) | 0,2 | | Anti-Scl-70, (%) | 11 (39,3) | 18 (43,9) | 0,8 | | Anticentromere, (%) | 5 (17,9) | 2 (4,8) | 0,1 | | Nucleolar ANA, (%) | 1 (3,6) | 9 (20,9) | 0,07 | | Upper GI involvement, % | 81,3 | 64,3 | 0,5 | | Interstitial lung disease, % | 50 | 65,3 | 0,2 | | Pulmonary hypertension + interstitial lung disease, % | 0 | 15,4 | 0,3 | | Isolated pulmonary hypertension, % | 4,8 | 2,6 | 0,3 | | Cardiac ultrasound abnormalities (aside from PHT), % | 4,5 | 10 | 0,6 | | Digital ulcers, % | 34,5 | 32,1 | 1 | | Renal crisis, | 0 | 1 | 1 |
|
|
